Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records

OBJECTIVE: To estimate the effectiveness of nirmatrelvir, compared with no treatment, in reducing admission to hospital or death at 30 days in people infected with the SARS-CoV-2 virus and at risk of developing severe disease, according to vaccination status and history of previous SARS-CoV-2 infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yan, Bowe, Benjamin, Al-Aly, Ziyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086514/
https://www.ncbi.nlm.nih.gov/pubmed/37041016
http://dx.doi.org/10.1136/bmj-2022-073312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086514/
https://www.ncbi.nlm.nih.gov/pubmed/37041016
http://dx.doi.org/10.1136/bmj-2022-073312

Ejemplares similares